Skip to main content

Table 2 Follow-up and overall survival

From: Surgery of highly eloquent gliomas primarily assessed as non-resectable: risks and benefits in a cohort study

 

mean follow-up (months)

mean overall survival (months)

primary

recurrent

primary

recurrent

WHO grade I

47.9

-

alive

-

WHO grade II

38.3

26.0

all alive

all alive

WHO grade III

21.6

22.0

all alive

20.5

WHO grade IV

8.6

7.9

5.1

6.0

  1. Columns 2 & 3: mean follow-up for alive patients. Columns 4 & 5: overall survival of deceased patients. This series only contains one patient with initially diagnosed WHO grade I glioma. When patients are alive, mean overall survival equals to mean follow-up.